Загрузка...
Seeing is believing: anti-PD-1/PD-L1 monoclonal antibodies in action for checkpoint blockade tumor immunotherapy
Structural immunology, focusing on structures of host immune related molecules, enables the immunologists to see what the molecules look like, and more importantly, how they work together. Antibody-based PD-1/PD-L1 blockade therapy has achieved brilliant successes in clinical applications. The recen...
Сохранить в:
| Опубликовано в: : | Signal Transduct Target Ther |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5661648/ https://ncbi.nlm.nih.gov/pubmed/29263905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sigtrans.2016.29 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|